Terms: = Colorectal cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha
630 results:
1. LncRNA ANRIL Promotes Glucose Metabolism and Proliferation of Colon cancer in a High-Glucose Environment and is Associated with Worse Outcome in Diabetic Colon cancer Patients.
Mosaad H; Shalaby SM; Mahmoud NM; Ahmed MM; Fayed A; Ashour HR; Sarhan W
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1371-1381. PubMed ID: 38679999
[TBL] [Abstract] [Full Text] [Related]
2. The Tumor Microenvironment Mediates the HIF-1α/PD-L1 Pathway to Promote Immune Escape in colorectal cancer.
Sun J; Zhao Z; Lu J; An W; Zhang Y; Li W; Yang L
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612546
[TBL] [Abstract] [Full Text] [Related]
3. Isthmin-1 promotes growth and progression of colorectal cancer through the interaction with EGFR and YBX-1.
Zhou X; Zhang K; Wang C; Teng Y; Yu P; Cai W; Gao W; Li M; Ding Y; Sun P; Chen F; Wang Y; Ma J; Maeshige N; Ma X; Li Q; Liang X; Zhang Y; Su D
Cancer Lett; 2024 May; 590():216868. PubMed ID: 38593920
[TBL] [Abstract] [Full Text] [Related]
4. Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways.
D'Antona S; Porro D; Gallivanone F; Bertoli G
Comput Biol Med; 2024 May; 174():108346. PubMed ID: 38581999
[TBL] [Abstract] [Full Text] [Related]
5. Synthesis and biological evaluation of echinomycin analogues as potential colon cancer agent.
Kojima K; Konishi H; Momosaki K; Komatani Y; Katsuyama A; Nakagawa K; Kanamitsu K; Yakushiji F; Fujiya M; Ichikawa S
Sci Rep; 2024 Apr; 14(1):7628. PubMed ID: 38561454
[TBL] [Abstract] [Full Text] [Related]
6. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
[TBL] [Abstract] [Full Text] [Related]
7. HIF-1α Mediates Immunosuppression and Chemoresistance in colorectal cancer by Inhibiting CXCL9, -10 and -11.
Su Y; Liu J; Tian Y; Dong H; Shi M; Zhang J; Li W; Huang Q; Xiang N; Wang C; Liu J; He L; Hu L; Haberman AM; Liu H; Yang X
Biomed Pharmacother; 2024 Apr; 173():116427. PubMed ID: 38484558
[TBL] [Abstract] [Full Text] [Related]
8. MITF regulates the subcellular location of HIF1α through SUMOylation to promote the invasion and metastasis of daughter cells derived from polyploid giant cancer cells.
Zheng M; Tian S; Zhou X; Yan M; Zhou M; Yu Y; Zhang Y; Wang X; Li N; Ren L; Zhang S
Oncol Rep; 2024 May; 51(5):. PubMed ID: 38456491
[TBL] [Abstract] [Full Text] [Related]
9. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
[TBL] [Abstract] [Full Text] [Related]
10. Magnetic resonance imaging-based approaches for detecting the efficacy of combining therapy following VEGFR-2 and PD-1 blockade in a colon cancer model.
Xu X; Ma M; Ye K; Zhang D; Chen X; Wu J; Mo X; Xiao Z; Shi C; Luo L
J Transl Med; 2024 Feb; 22(1):198. PubMed ID: 38395884
[TBL] [Abstract] [Full Text] [Related]
11. Post-surgery financial toxicity and its influencing factors in colorectal cancer care: A cross-sectional study.
Shao M; Yao L; Zhang M; Zhou H; Ding Y; Bai L; Ma B; Li T; Guo S; Chen C; Wang T
Eur J Oncol Nurs; 2024 Feb; 68():102518. PubMed ID: 38309254
[TBL] [Abstract] [Full Text] [Related]
12. NAMPT-Driven M2 Polarization of Tumor-Associated Macrophages Leads to an Immunosuppressive Microenvironment in colorectal cancer.
Hong SM; Lee AY; Kim BJ; Lee JE; Seon SY; Ha YJ; Ng JT; Yoon G; Lim SB; Morgan MJ; Cha JH; Lee D; Kim YS
Adv Sci (Weinh); 2024 Apr; 11(14):e2303177. PubMed ID: 38308188
[TBL] [Abstract] [Full Text] [Related]
13. Extracellular vesicles from
Shi Y; Zhang C; Cao W; Li L; Liu K; Zhu H; Balcha F; Fang Y
Future Microbiol; 2024 Feb; 19():227-239. PubMed ID: 38270125
[No Abstract] [Full Text] [Related]
14. Challenging the anticolorectal cancer capacity of quinoxaline-based scaffold via triazole ligation unveiled new efficient dual VEGFR-2/MAO-B inhibitors.
Ayoup MS; Ammar A; Abdel-Hamid H; Amer A; Abu-Serie MM; Nasr SA; Ghareeb DA; Teleb M; Tageldin GN
Bioorg Chem; 2024 Feb; 143():107102. PubMed ID: 38211551
[TBL] [Abstract] [Full Text] [Related]
15. The emerging role of hypoxia and environmental factors in inflammatory bowel disease.
Villareal LB; Xue X
Toxicol Sci; 2024 Mar; 198(2):169-184. PubMed ID: 38200624
[TBL] [Abstract] [Full Text] [Related]
16. Human colorectal cancer: upregulation of the adaptor protein Rai in TILs leads to cell dysfunction by sustaining GSK-3 activation and PD-1 expression.
Montecchi T; Nannini G; De Tommaso D; Cassioli C; Coppola F; Ringressi MN; Carraro F; Naldini A; Taddei A; Marotta G; Amedei A; Baldari CT; Ulivieri C
Cancer Immunol Immunother; 2024 Jan; 73(1):2. PubMed ID: 38175205
[TBL] [Abstract] [Full Text] [Related]
17. Long non-coding RNA NBR2 suppresses the progression of colorectal cancer by downregulating miR-19a to regulate M2 macrophage polarization.
Yang X; Luo Y; Li M; Jin Z; Chen G; Gan C
Chin J Physiol; 2023; 66(6):546-557. PubMed ID: 38149567
[TBL] [Abstract] [Full Text] [Related]
18. HIF-1α/METTL1/m
Mi S; Cai S; Xue M; Wu W
Biochem Biophys Res Commun; 2024 Jan; 693():149385. PubMed ID: 38118310
[TBL] [Abstract] [Full Text] [Related]
19. 1,8-Dihydroxy-3-methoxy-anthraquinone inhibits tumor angiogenesis through HIF-1α downregulation.
Hwang SJ; Cho SH; Bang HJ; Hong JH; Kim KH; Lee HJ
Biochem Pharmacol; 2024 Feb; 220():115972. PubMed ID: 38072164
[TBL] [Abstract] [Full Text] [Related]
20. Unveiling the role of hypoxic macrophage-derived exosomes in driving colorectal cancer progression.
Jiang J; Wang W; Zhu L; Shi B; Chen Y; Xia Y; Feng W; Yao W; Lu A; Zhang H
Front Immunol; 2023; 14():1260638. PubMed ID: 38022589
[TBL] [Abstract] [Full Text] [Related]
[Next]
